Kenneth Carter, PhD
Leading Edge Seminars
Live Broadcast Date: Thursday, April 29th, 2021
Live Broadcast Time: 1:00 pm to 4:15 pm, ET
Follow-up Q & A Session
Live Broadcast Date: Tuesday, May 11, 2021
Live Broadcast Time: 12:00 pm – 1:00 pm ET
Can’t Attend Live? This webinar and Follow-up Q&A will be recorded and archived. All registrants will be given unlimited access to the recording for a full year after the Live Broadcast date.
The COVID-19 pandemic is a particularly relevant threat to people with mental health challenges. Uncertainty and anxiety, social distancing/isolation, loneliness and economic repercussions can greatly exacerbate an existing condition. At the same time, the long-term side effects of psychotropic drugs, physical health problems, substance use disorders and medication non-adherence are also being observed.
Mental health professionals without medical training often see clients on multiple medications that can influence behaviour, response to interventions and the ability to succeed in therapy. Furthermore, clients often do not fully understand why they are taking their medications and may even be unclear about who prescribed them in the first place. Despite the confusion, you still have a responsibility to know the symptoms and reactions to your clients’ medications, as well as to coordinate their care.
In this workshop, Kenneth Carter will give a thorough overview of psychopharmacology basics, with a focus on the most widely prescribed medications now. This knowledge will enable you to advocate effectively and safely for your clients. Kenneth will also share the latest information about the therapeutic effects, strengths and possible problems associated with the most commonly prescribed medications, such as those used to treat depression, anxiety and insomnia. You will learn how medications work and will be made aware of their official health warnings. You will also have a chance to explore the ethical decisions that surround the use of psychotropic medications. What’s more, you’ll hear about COVID-19’s impact on psychopharmacology.
After this dynamic training, you will be more equipped to support and educate your clients and better able to communicate with prescribing medical professionals.
Kenneth Carter, PhD, ABPP, is a board-certified clinical psychologist and professor of psychology at Oxford College of Emory University in Atlanta, Georgia. Dr. Carter received his MA and PhD in clinical psychology from the University of Michigan in Ann Arbor and a postdoctoral master’s degree in clinical psychopharmacology from Fairleigh Dickerson University. Dr. Carter has taught clinical psychopharmacology classes at Emory University since 2005 and has presented highly rated Psychopharmacology workshops to clinicians throughout the United States since 2010.
Dr. Carter has served as a senior assistant research scientist in the Epidemic Intelligence Service of the Centers for Disease Control and Prevention. He has been a psychotherapist and researcher for more than 20 years, during which time he has garnered awards from the National Institutes of Health, the National Heart, Lung and Blood Institute, and the University of Michigan. Dr. Carter has presented at numerous conferences and written several books and articles on introductory psychology, neuropsychology, and psychopharmacology.
For more information, see www.drkencarter.com.